InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

- Current share price for RHT : $0.083

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$40 HepaFat-AI gains US FDA clearance 9 Dec 2020 10:23AM $0.155 $0.083 fallen by 46.45%
$40 Trading Halt 8 Dec 2020 10:49AM $0.155 $0.083 fallen by 46.45%
$40 Pause in Trading 8 Dec 2020 10:36AM $0.155 $0.083 fallen by 46.45%
$40 Secondary Trading Notice & Appendix 2A 27 Nov 2020 2:15PM $0.160 $0.083 fallen by 48.13%
$40 Results of Meeting 19 Nov 2020 3:39PM $0.170 $0.083 fallen by 51.18%
$40 Investor Presentation November 2020 19 Nov 2020 12:22PM $0.175 $0.083 fallen by 52.57%
$40 Appendix 4C - quarterly 26 Oct 2020 9:48AM $0.160 $0.083 fallen by 48.13%
$40 Notice of Annual General Meeting/Proxy Form 16 Oct 2020 11:46AM $0.160 $0.083 fallen by 48.13%
$40 Secondary Trading Notice & Appendix 2A 9 Oct 2020 2:40PM $0.170 $0.083 fallen by 51.18%
$40 New Pulmonary Embolism AI Solution Developed 6 Oct 2020 8:20AM $0.160 $0.083 fallen by 48.13%
$40 Appendix 4G and Corporate Governance Statement 30 Sep 2020 12:50PM $0.160 $0.083 fallen by 48.13%
$40 Annual Report to shareholders 30 Sep 2020 12:49PM $0.160 $0.083 fallen by 48.13%
$40 Proposed issue of Securities - RHT 10 Sep 2020 12:33PM $0.150 $0.083 fallen by 44.67%
$40 Execution of Licence Agreement 10 Sep 2020 12:16PM $0.135 $0.083 fallen by 38.52%
$40 Preliminary Final Report 20 Aug 2020 9:22AM $0.140 $0.083 fallen by 40.71%
$40 Appendix 4C - quarterly 28 Jul 2020 8:16AM $0.155 $0.083 fallen by 46.45%
$40 Additional Information on Announcement Dated 25 May 2020 26 May 2020 10:28AM $0.180 $0.083 fallen by 53.89%
$40 Resonance Health Files New Provisional Patent 25 May 2020 9:24AM $0.170 $0.083 fallen by 51.18%
$40 Appendix 4C - quarterly 28 Apr 2020 8:22AM $0.120 $0.083 fallen by 30.83%
$40 510(k) Application Submission to U.S. FDA 6 Apr 2020 8:28AM $0.120 $0.083 fallen by 30.83%
$40 Market Update 31 Mar 2020 8:28AM $0.098 $0.083 fallen by 15.31%
$40 Secondary Trading Notice & Appendix 2A 20 Mar 2020 3:01PM $0.110 $0.083 fallen by 24.55%
$40 Proposed issue of Securities - RHT 19 Mar 2020 7:22PM $0.105 $0.083 fallen by 20.95%
$40 Controlled Placement Facility 19 Mar 2020 7:17PM $0.105 $0.083 fallen by 20.95%
$40 Secondary Trading Notice & Appendix 2A 6 Mar 2020 3:17PM $0.148 $0.083 fallen by 43.73%

201 - 225 of 534 results

Page 9 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.